| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,902,369 | 4,892,363 | 3,739,269 | 1,137,283 | | Cost of Revenue | 4,550,064 | 4,420,133 | 2,748,803 | 880,665 | | | Gross Profit | 2,352,305 | 472,229 | 990,466 | 256,617 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,255,835 | 10,920 | 509,245 | 212,615 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 246,455 | 179,807 | 157,738 | 65,742 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 850,016 | 281,502 | 323,483 | (21,740) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,597 | (995) | (1,601) | (1,927) | | Earnings Before Interest And Taxes | 852,612 | 280,507 | 321,881 | (23,667) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 852,612 | 280,507 | 321,881 | (23,667) | | Income Tax Expense | 238,631 | 80,890 | 90,479 | (96,170) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 613,981 | 199,617 | 231,402 | 72,503 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 613,981 | 199,617 | 231,402 | 72,503 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $613,981 | $199,617 | $231,402 | $72,503 |
|
0.02% Nasdaq 
0.33%
Income Statement
